Cost-effectiveness of subdermal implantable buprenorphine versus sublingual buprenorphine to treat opioid use disorder.
J Med Econ. 2017 Aug;20(8):893-901. doi: 10.1080/13696998.2017.1341416. Epub 2017 Jun 22.
J Med Econ. 2017.
PMID: 28604141
Free article.